home · filing · 0000950170-23-012492
8-K
filed April 12, 2023, 7:59 PM ET
ticker CUE
CIK 0001645460
leadership
confidence high
sentiment neutral
materiality 0.30
Cue Biopharma appoints Patrick Verheyen to Board of Directors
Cue Biopharma, Inc.
Patrick Verheyen appointed to the Board on April 11, 2023.
Granted option to purchase 40,000 shares vesting over 3 years.
Compensation per Director Compensation Policy filed as Exhibit 10.1.
No reportable transactions or arrangements with any other person.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Patrick Verheyen
Director
CUE ·
Cue Biopharma, Inc.
Effective 2023-04-11
Filed April 12, 2023, 7:59 PM ET
On April 11, 2023, Patrick Verheyen was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Patrick Verheyen was appointed as Director at Cue Biopharma, Inc..
Action appointed
Role Director
Exact text from the filing
On April 11, 2023, Patrick Verheyen was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc.
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-23-012492
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.